MMP9 and non-small cell lung carcinoma: Another group confirmed that EEOS reduced MMP-9 and urokinase plasminogen activator activity in non-small cell lung cancer cells (NCI-H460) by inhibiting the PI3K/Akt signalling pathway (Kwak et al., 2014).